0001209191-15-063312.txt : 20150803 0001209191-15-063312.hdr.sgml : 20150801 20150803171836 ACCESSION NUMBER: 0001209191-15-063312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150731 FILED AS OF DATE: 20150803 DATE AS OF CHANGE: 20150803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-287-2410 MAIL ADDRESS: STREET 1: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haqq Christopher CENTRAL INDEX KEY: 0001612095 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 151023280 MAIL ADDRESS: STREET 1: C/O ATARA BIOTHERAPEUTICS, INC. STREET 2: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-07-31 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001612095 Haqq Christopher 701 GATEWAY BOULEVARD SUITE 200 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2015-07-31 4 S 0 2500 55.43 D 246665 D Common Stock 20000 I See footnote Transaction pursuant to Rule 10b5-1 Plan adopted March 11, 2015. The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee. /s/ Tina Gullotta, Attorney-in-Fact for Christopher Haqq 2015-08-03